Skip to main content
iwCLL 2025 Main banner
Final Program


Save The Date

    Oral

    (1024) ROR1-Signaling Enhances Survival and Drug-Resistance of del(17p)/TP53-Mutated CLL by Mitigating Oxidative Stress Via Activation of NRF2

    Saturday, September 13, 2025
    09:50 - 10:00 CEST
    Location: ICE, Auditorium Hall (S1), Entrances On Level 0 & 1
    Oral

      Primary Author / Presenter(s)

    • EG

      Emanuela M. Ghia, PhD

      Scientific Director of Biobanking and Correlative Sciences; Project Scientist
      Center for Novel Therapeutics; University of California, San Diego
      La Jolla, California, United States